| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Legal Officer | EVP, General Counsel
1 company
Davis George Eric is an EVP, Chief Legal Officer at BIOMARIN PHARMACEUTICAL INC. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $4.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 5, 2018 | BMRN Biomarin Pharmaceutical Inc | EVP, General Counsel | Sell | 2,105 | $79.04 | $166,379.20 | -2.3% | |
| Feb 1, 2018 | BMRN Biomarin Pharmaceutical Inc | EVP, General Counsel | Sale+OE | 30,000 | $90.66 | $2,719,665.00 | -26.6% | |
| Nov 30, 2017 | BMRN Biomarin Pharmaceutical Inc | EVP, General Counsel | Sell | 1,200 | $85.64 | $102,766.80 | -1.4% | |
| Jun 23, 2017 | BMRN Biomarin Pharmaceutical Inc | EVP, General Counsel | Sale+OE | 9,844 | $96.60 | $950,930.40 | -10.5% | |
| Jun 5, 2017 | BMRN Biomarin Pharmaceutical Inc | EVP, General Counsel | Sell | 9,471 | $91.04 | $862,230.37 | -11.3% | |
| May 5, 2017 | BMRN Biomarin Pharmaceutical Inc | EVP, General Counsel | Sale+OE | 2,500 | $100.34 | $250,852.50 | -2.8% | |
| Mar 16, 2017 | BMRN Biomarin Pharmaceutical Inc | EVP, General Counsel | Sell | 2,238 | $91.96 | $205,806.48 | -2.9% | |
| Mar 6, 2017 | BMRN Biomarin Pharmaceutical Inc | EVP, General Counsel | Sell | 1,498 | $93.32 | $139,793.36 | -1.9% | |
| Nov 18, 2016 | BMRN Biomarin Pharmaceutical Inc | EVP, General Counsel | Sale+OE | 5,000 | $90.42 | $452,100.00 | -6.6% | |
| Aug 1, 2016 | BMRN Biomarin Pharmaceutical Inc | EVP, General Counsel | Sell | 2,167 | $100.00 | $216,700.00 | -3.0% |